Stephen Huang

Stephen Huang has a strong background in biomarkers and companion diagnostics, with experience in various pharmaceutical and biotech companies such as Avenzo Therapeutics, Artiva Biotherapeutics, Turning Point Therapeutics, AbbVie, Spectrum Pharmaceuticals, Pfizer, Exelixis, and Quest Diagnostics. Stephen has held positions ranging from Principal Scientist to Executive Director, focusing on translational medicine, oncology, and precision medicine.